pre-update Archives

Announcement

Certara 收购 Formedix LLC 旨在提高临床试验数据标准化，加快研究设计、分析和递交时间

Formedix ryze cloud based clinical metadata repository and SDTM automation suite and Certara Pinnacle 21…

Certara2023 年 10 月 10 日

博客

扩大规模和批准后变更 (SUPAC) 指导文件是否仍适用于药物开发人员？

Do you remember the 1990s? The Soviet Union fell, Friends was the most popular TV…

Certara2023 年 10 月 6 日

Conference

GMP 2024 Symposium

Certara2023 年 10 月 5 日

Announcement

Certara 推出生命科学专用 GPT 平台 Certara.AI

Certara.AI Improves Drug Research & Development Processes with Secure, Client-Specific, A.I. Applications PRINCETON, N. J.—October…

Certara2023 年 10 月 5 日

Publication

利用定量系统药理学模型分析神经退行性病变中抗 Tau 和抗突触核蛋白抗体的临床失败案例

Hugo Geerts, Silke Bergeler, Mike Walker, Piet van der Graaf, Jean-Philippe Courade. Sci Rep. 2023…

Certara2023 年 10 月 5 日

Press Coverage

How Modeling Can Help to Improve Children’s Access to Properly Evaluated Medications

Regulatory guidance paves the way to address ethical concerns in pediatric trials, and how additional…

Certara2023 年 10 月 5 日

On-Demand Webinar

Clinical Pharmacology Issues That Can Lead to Approvability Problems for Your Drug

临床药理信息占药品说明书的 50% 以上。Inadequate clinical pharmacology development…

Certara2023 年 10 月 4 日

Announcement

Certara Launches CoAuthor, a Regulatory and Medical Writing Tool

Using AI to gain efficiencies for medical writers PRINCETON, N. J.— 2023 年 10 月 3 日— Certara,…

Certara2023 年 10 月 3 日

On-Demand Webinar

Unlocking ROI through Omnichannel Stakeholder Engagement and Value Communication in Pharma

In a sector where both competition and stakeholder expectations are high, a comprehensive approach that…

Certara2023 年 10 月 2 日

Blog

开发针对不同种族群体的儿科 PBPK 模型

Physiologically-based pharmacokinetic (PBPK) modeling has proven invaluable in drug development, especially for pediatric populations, because…

Certara2023 年 9 月 29 日

pre-update

Certara 收购 Formedix LLC 旨在提高临床试验数据标准化，加快研究设计、分析和递交时间

扩大规模和批准后变更 (SUPAC) 指导文件是否仍适用于药物开发人员？

GMP 2024 Symposium

Certara 推出生命科学专用 GPT 平台 Certara.AI

利用定量系统药理学模型分析神经退行性病变中抗 Tau 和抗突触核蛋白抗体的临床失败案例

How Modeling Can Help to Improve Children’s Access to Properly Evaluated Medications

Clinical Pharmacology Issues That Can Lead to Approvability Problems for Your Drug

Certara Launches CoAuthor, a Regulatory and Medical Writing Tool

Unlocking ROI through Omnichannel Stakeholder Engagement and Value Communication in Pharma

开发针对不同种族群体的儿科 PBPK 模型

订阅时事通讯

快捷链接

解决方案

联系我们